Catasys Inc. (NASDAQ:CATS) has been assigned an average broker rating score of 1.50 (Buy) from the two analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating and one has given a strong buy rating to the company. Catasys’ rating score has declined by 50% from 90 days ago as a result of various analysts’ ratings changes.
Brokers have set a twelve-month consensus price objective of $8.65 for the company and are anticipating that the company will post ($0.09) EPS for the current quarter, according to Zacks. Zacks has also given Catasys an industry rank of 219 out of 265 based on the ratings given to its competitors.
Several brokerages have recently weighed in on CATS. Telsey Advisory Group began coverage on shares of Catasys in a research report on Wednesday, October 18th. They set a “buy” rating on the stock. Taglich Brothers began coverage on shares of Catasys in a research report on Wednesday, October 18th. They set a “speculative buy” rating and a $8.00 target price on the stock. Finally, ValuEngine lowered shares of Catasys from a “hold” rating to a “sell” rating in a research report on Saturday, October 21st.
Institutional investors have recently modified their holdings of the company. UBS Oconnor LLC acquired a new stake in shares of Catasys during the 2nd quarter valued at about $834,000. Bard Associates Inc. acquired a new stake in shares of Catasys during the 2nd quarter valued at about $1,012,000. Kennedy Capital Management Inc. acquired a new stake in shares of Catasys during the 2nd quarter valued at about $1,385,000. Finally, FNY Partners Fund LP acquired a new position in Catasys in the second quarter valued at about $1,560,000. Institutional investors and hedge funds own 6.39% of the company’s stock.
Catasys Company Profile
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The companys OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.